??
MOU2 likely delayed and not coming out this month, which had previously been priced into the SP.
How that doesn't classify as a change in circumstances, I will never understand.
Anyway, if you want to hold, that's your decision. Never said it was bad, just brave. For me personally, the risk isn't worth it and I am no longer holding. I will see where the SP is when the dust settles and decide if I want to re-enter. Don't really feel like catching falling knives.
- Forums
- ASX - By Stock
- CF1
- Ann: Intiger Market Update
Ann: Intiger Market Update, page-71
Featured News
Add CF1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.86M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 466724 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.5¢ | 201058 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 466724 | 0.021 |
1 | 250000 | 0.020 |
1 | 1025000 | 0.018 |
1 | 100000 | 0.017 |
1 | 50000 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.025 | 201058 | 2 |
0.026 | 463790 | 3 |
0.027 | 64744 | 1 |
0.028 | 57143 | 1 |
0.029 | 489168 | 2 |
Last trade - 11.08am 13/11/2024 (20 minute delay) ? |
Featured News
CF1 (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online